Simple Summary Taking into consideration the high risk of patients with cancer for severe
COVID-19 infection, prioritization has been given to primary prevention with both primary …

Patients receiving chimeric antigen receptor T cell (CAR-T) therapy may have impaired
humoral responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Ovarian cancer (OC) is one of the three major gynecologic malignancies and has the
highest mortality rate because of the late diagnosis. Liquid biopsy based on serum protein …

Background Although the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccines are highly efficacious at preventing severe disease in the general population …

Vaccination has been a cornerstone of public health, substantially reducing the global
burden of infectious diseases, notably evident during the COVID-19 pandemic caused by …

Methods A single-center retrospective study of adults receiving CD19 or BCMA-directed
CAR T-cell therapy for B-cell non-Hodgkin lymphoma or multiple myeloma was conducted …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine booster is one
of the most essential strategies against coronavirus disease 2019 (COVID-19) in the era of …

Inactivated COVID-19 vaccines data in immunocompromised individuals are scarce. This
trial assessed the immunogenicity of two CoronaVac doses and additional BNT162b2 …

Quilombo remnant communities are areas officially recognized by the Brazilian government
as historical communities founded by formerly enslaved individuals. These communities are …

Heterologous COVID-19 vaccine boosters have not been evaluated for patients with
hematological malignancies. A Novavax booster was administered for 56 individuals with …